Breaking News
May 3, 2019 - Vaping and Smoking May Signal Greater Motivation to Quit
May 3, 2019 - Dementia looks different in brains of Hispanics
May 3, 2019 - Short-Staffed Nursing Homes See Drop In Medicare Ratings
May 3, 2019 - Study of teens with eating disorders explores how substance users differ from non-substance users
May 3, 2019 - Scientists develop new video game that may help in the study of Alzheimer’s
May 3, 2019 - Arc Bio introduces Galileo Pathogen Solution product line at ASM Clinical Virology Symposium
May 3, 2019 - Cornell University study uncovers relationship between starch digestion gene and gut bacteria
May 3, 2019 - How to Safely Use Glucose Meters and Test Strips for Diabetes
May 3, 2019 - Anti-inflammatory drugs ineffective for prevention of Alzheimer’s disease
May 3, 2019 - Study tracks Pennsylvania’s oil and gas waste-disposal practices
May 3, 2019 - Creating a better radiation diagnostic test for astronauts
May 3, 2019 - Vegans are often deficient in these four nutrients
May 3, 2019 - PPDC announces seed grants to develop medical devices for children
May 3, 2019 - Study maps out the frequency and impact of water polo head injuries
May 3, 2019 - Research on Reddit identifies risks associated with unproven treatments for opioid addiction
May 3, 2019 - Good smells may help ease tobacco cravings
May 3, 2019 - Medical financial hardship found to be very common among people in the United States
May 3, 2019 - Researchers develop multimodal system for personalized post-stroke rehabilitation
May 3, 2019 - Study shows significant mortality benefit with CABG over percutaneous coronary intervention
May 3, 2019 - Will gene-editing of human embryos ever be justifiable?
May 3, 2019 - FDA Approves Dengvaxia (dengue vaccine) for the Prevention of Dengue Disease in Endemic Regions
May 3, 2019 - Why Tonsillitis Keeps Coming Back
May 3, 2019 - Fighting the opioid epidemic with data
May 3, 2019 - Maggot sausages may soon be a reality
May 3, 2019 - Deletion of ATDC gene prevents development of pancreatic cancer in mice
May 2, 2019 - Targeted Therapy Promising for Rare Hematologic Cancer
May 2, 2019 - Alzheimer’s disease is a ‘double-prion disorder,’ study shows
May 2, 2019 - Reservoir bugs: How one bacterial menace makes its home in the human stomach
May 2, 2019 - Clinical, Admin Staff From Cardiology Get Sneak Peek at Epic
May 2, 2019 - Depression increases hospital use and mortality in children
May 2, 2019 - Vicon and NOC support CURE International to create first gait lab in Ethiopia
May 2, 2019 - Researchers use 3D printer to make paper organs
May 2, 2019 - Viral infection in utero associated with behavioral abnormalities in offspring
May 2, 2019 - U.S. Teen Opioid Deaths Soaring
May 2, 2019 - Opioid distribution data should be public
May 2, 2019 - In the Spotlight: “I’m learning every single day”
May 2, 2019 - 2019 Schaefer Scholars Announced
May 2, 2019 - Podcast: KHN’s ‘What The Health?’ Bye-Bye, ACA, And Hello ‘Medicare-For-All’?
May 2, 2019 - Study describes new viral molecular evasion mechanism used by cytomegalovirus
May 2, 2019 - SLU study suggests a more equitable way for Medicare reimbursement
May 2, 2019 - Scientists discover first gene involved in lower urinary tract obstruction
May 2, 2019 - Researchers identify 34 genes associated with increased risk of ovarian cancer
May 2, 2019 - Many low-income infants receive formula in the first few days of life, finds study
May 2, 2019 - Global study finds high success rate for hip and knee replacements
May 2, 2019 - Taking depression seriously: What is it?
May 2, 2019 - With Head Injuries Mounting, Will Cities Put Their Feet Down On E-Scooters?
May 2, 2019 - Scientists develop small fluorophores for tracking metabolites in living cells
May 2, 2019 - Study casts new light into how mothers’ and babies’ genes influence birth weight
May 2, 2019 - Researchers uncover new brain mechanisms regulating body weight
May 2, 2019 - Organ-on-chip systems offered to Asia-Pacific regions by Sydney’s AXT
May 2, 2019 - Adoption of new rules drops readmission penalties against safety net hospitals
May 2, 2019 - Kids and teens who consume zero-calorie sweetened beverages do not save calories
May 2, 2019 - Improved procedure for cancer-related erectile dysfunction
May 2, 2019 - Hormone may improve social behavior in autism
May 2, 2019 - Alzheimer’s disease may be caused by infectious proteins called prions
May 2, 2019 - Even Doctors Can’t Navigate Our ‘Broken Health Care System’
May 2, 2019 - Study looks at the impact on criminal persistence of head injuries
May 2, 2019 - Honey ‘as high in sugars as table sugar’
May 2, 2019 - Innovations to U.S. food system could help consumers in choosing healthy foods
May 2, 2019 - FDA Approves Mavyret (glecaprevir and pibrentasvir) as First Treatment for All Genotypes of Hepatitis C in Pediatric Patients
May 2, 2019 - Women underreport prevalence and intensity of their own snoring
May 2, 2019 - Concussion summit focuses on science behind brain injury
May 2, 2019 - Booker’s Argument For Environmental Justice Stays Within The Lines
May 2, 2019 - Cornell research explains increased metastatic cancer risk in diabetics
May 2, 2019 - Mount Sinai study provides fresh insights into cellular pathways that cause cancer
May 2, 2019 - Researchers to study link between prenatal pesticide exposures and childhood ADHD
May 2, 2019 - CoGEN Congress 2019: Speakers’ overviews
May 2, 2019 - A new strategy for managing diabetic macular edema in people with good vision
May 2, 2019 - Sagent Pharmaceuticals Issues Voluntary Nationwide Recall of Ketorolac Tromethamine Injection, USP, 60mg/2mL (30mg per mL) Due to Lack of Sterility Assurance
May 2, 2019 - Screen time associated with behavioral problems in preschoolers
May 2, 2019 - Hormone reduces social impairment in kids with autism | News Center
May 2, 2019 - Researchers synthesize peroxidase-mimicking nanozyme with low cost and superior catalytic activity
May 2, 2019 - Study results of a potential drug to treat Type 2 diabetes in children announced
May 2, 2019 - Multigene test helps doctors to make effective treatment decisions for breast cancer patients
May 2, 2019 - UNC School of Medicine initiative providing unique care to dementia patients
May 2, 2019 - Nestlé Health Science and VHP join forces to launch innovative COPES program for cancer patients
May 2, 2019 - Study examines how our brain generates consciousness and loses it during anesthesia
May 2, 2019 - Transition Support Program May Aid Young Adults With Type 1 Diabetes
May 2, 2019 - Study shows how neutrophils exacerbate atherosclerosis by inducing smooth muscle-cell death
May 2, 2019 - Research reveals complexity of how we make decisions
Overlooked immune cells could play a key role in cancer immunotherapy, claims new study

Overlooked immune cells could play a key role in cancer immunotherapy, claims new study

Cancer immunotherapy is an attractive and relatively newer method of treating cancer by enhancing the combat-readiness of the host immune system against cancer cells. It has succeeded with some refractory tumors. However, it doesn’t always work, and the question remains, why not?

CI Photos | Shutterstock

Researchers in this field have mostly examined the role played by CD8+ cells, a type of T lymphocyte which recognizes and eliminates cells in the body on which cancer antigens are found. A cancer antigen is an abnormal protein formed from a mutated gene.

In this process, the contribution of CD4+ T cells to the fight against cancer antigens was overlooked, but these cells have gained new importance following the publication of a study in Cell, on September 20.

The new study revolves around a bioinformatics-centered analysis of the Major Histocompatibility Complex (MHC), a molecular family found prominently on the surface of most of the cells in the body. There are two types of MHC molecules, namely, MHC-I and MHC-II.

These are concerned with presenting antigenic molecules from every type of antigen within the cell, whether belonging to the cell or not. Only then can these antigens be recognized by patrolling T cells. If they are “self” antigens, the T cells do not react to them. However, if the antigens are “foreign”, either from viruses, bacteria or oncoproteins, instant T cell-mediated killing of the infected or tumorous cell occurs.

MHC-I molecules are found on all cell surfaces. MHC-II molecules are found only on the surface of immune cells, like macrophages. These molecules are both more complex and able to bind antigens of a greater variety than can MHC-I molecules. The MHC-I and MHC-II molecules thus complement each other, making it less likely that a mutated cell will escape both systems.

The more we know about the ability of a person’s immune system to clear cancer cells before they take hold, and the more we can combine that with other information about their inherited risk factors or environmental exposures, the better we may get at predicting a person’s cancer susceptibility.”

Study leader and senior author Hannah Carter, PhD, assistant professor of medicine at UC San Diego School of Medicine.

An older study by the same authors published in Cell had already revealed that a cancer antigen bound by an MHC-I molecule was unlikely to surface later in any tumor developed by that individual. This is because any antigen presented by the MHC-I system leads to the immediate elimination of that cell.

Conversely, if the MHC-I molecules cannot present a particular antigen, it escapes surveillance and may eventually be found in a tumor in that individual. The less the number of cancer antigens recognized by the MHC-I system, the higher is the individual’s risk of developing cancer at an earlier age.

This type of research could ultimately help to predict which type of cancer a person is at risk for, the probable tumor behavior and the potentially useful treatment methods, even before a tumor develops.

The current study focused on the specific importance of MHC-II in immune cancer surveillance. Using computational biology, researchers analyzed data obtained from The Cancer Genome Atlas (TCGA), which is a database set up by the National Institutes of Health containing information on the genomes of thousands of human tumors of many types.

They retrieved data on the MHC-II antigen-presenting capability for 1018 cancer antigens, in 5942 tumors, scoring the tumors accordingly. As expected, antigens recognized by a person’s MHC-II molecules were unlikely to be present in a tumor developing in that individual, and vice versa. This association was similar to that observed for MHC-I tumor antigen recognition, but even stronger.

The surprise was finding that unlike MHC-I antigen recognition, the number of cancer antigens presented by the MHC-II system does not affect the age at which cancer eventually develops, at least according to this very early study.

More research is needed, because MHC-II molecules are more complex and recognize a wider range of antigens. More advanced tools are also required. However, the authors hope to see increased interest in evolving personalized cancer immunotherapy based on both MHC-I and MHC-II antigen recognition data.

For instance, readouts of MHC-I and MHC-II antigen presenting profiles could explain why patients respond differently to the same immunotherapy, or help predict the individual’s reaction to treatment. This can avoid the use of ineffective therapies, and thus bring down the rate of potentially serious adverse reactions.  

Bringing MHC into the big picture of cancer through genomic analysis is a powerful new way to integrate the master regulator of immunity into a better understanding of cancer evolution and its dynamic interplay with the immune system. This may represent a step forward in our ability to select the best form of immunotherapy for individual patients and likewise help better predict response to immunotherapy. I see this work as a major step to bridge cancer genomics and cancer immunity.”

Maurizio Zanetti, MD, study co-author, who is professor of medicine at UC San Diego School of Medicine and head of the Laboratory of Immunology at Moores Cancer Center.

Source:

https://www.eurekalert.org/pub_releases/2018-09/uoc–cim092018.php

Tagged with:

About author

Related Articles